KDIGO guidelines include FILSPARI for IgA nephropathy treatment
Go back to KDIGO guidelines include FILSPARI for IgA nephropathy treatment| CARLISLE COMPANIES, Inc. (NYSE: CSL) | Delayed: 327.21 -10.32 (3.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $337.53 | 52 Week High | $114.49 | |||
| Open | $334.49 | 52 Week Low | $75.17 | |||
| Day High | $334.49 | P/E | 90.64 | |||
| Day Low | $327.21 | EPS | $3.61 | |||
| Volume | 236,727 | |||||
| (AMEX: CSLLY) | Delayed: 30.14 -0.86 (2.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.00 | 52 Week High | $45.60 | |||
| Open | $30.22 | 52 Week Low | $33.39 | |||
| Day High | $30.98 | P/E | N/A | |||
| Day Low | $30.11 | EPS | $0.00 | |||
| Volume | 137,595 | |||||
| (NASDAQ: TVTX) | Delayed: 67.13 +0.91 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.22 | 52 Week High | $ | |||
| Open | $65.60 | 52 Week Low | $ | |||
| Day High | $68.59 | P/E | N/A | |||
| Day Low | $64.45 | EPS | $ | |||
| Volume | 922,369 | |||||

